Cargando…

SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are a class of novel oral anti-hyperglycemic agents which are increasingly used in clinical practice. SGLT-2 inhibitors improve glycemic control and cardiorenal outcomes, promote weight loss, and reduce blood pressure. Randomized controlled trials h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalay, Zeynepgul, Sahin, Ozgun E, Copur, Sidar, Danacı, Senem, Ortiz, Alberto, Yau, Kevin, Cherney, David Z I, Kanbay, Mehmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	CKJ Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871839/ https://www.ncbi.nlm.nih.gov/pubmed/36726436 http://dx.doi.org/10.1093/ckj/sfac189

Ejemplares similares

Intravenous fluid therapy in accordance with kidney injury risk: when to prescribe what volume of which solution
por: Kanbay, Mehmet, et al.
Publicado: (2022)

Donor obesity and weight gain after transplantation: two still overlooked threats to long-term graft survival
por: Kanbay, Mehmet, et al.
Publicado: (2022)

Novel strategies in nephrology: what to expect from the future?
por: Copur, Sidar, et al.
Publicado: (2022)

A new immune disease: systemic hypertension
por: Copur, Sidar, et al.
Publicado: (2023)

A primer on metabolic memory: why existing diabesity treatments fail
por: Copur, Sidar, et al.
Publicado: (2020)

The association between acute kidney injury and outcomes in cancer patients receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysis
por: Kanbay, Mehmet, et al.
Publicado: (2022)

Early aging and premature vascular aging in chronic kidney disease
por: Tanriover, Cem, et al.
Publicado: (2023)

Proteinuria in COVID-19
por: Mohamed, Muner M B, et al.
Publicado: (2021)

Sweet dreams: therapeutic insights, targeting imaging and physiologic evidence linking sleep, melatonin and diabetic nephropathy
por: Afsar, Baris, et al.
Publicado: (2020)

An update review of intradialytic hypotension: concept, risk factors, clinical implications and management
por: Kanbay, Mehmet, et al.
Publicado: (2020)

Sodium–glucose cotransporter inhibition in polycystic kidney disease: fact or fiction
por: Afsar, Baris, et al.
Publicado: (2022)

Should we continue to use renin–angiotensin–aldosterone system blockers in patients with COVID-19?
por: Copur, Sidar, et al.
Publicado: (2022)

A brand-new cardiorenal syndrome in the COVID-19 setting
por: Apetrii, Mugurel, et al.
Publicado: (2020)

The new Clinical Kidney Journal, 4 years later
por: Ortiz, Alberto, et al.
Publicado: (2019)

Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)
por: Sarafidis, Pantelis, et al.
Publicado: (2023)

Increase in the global burden of chronic kidney disease: might it be attributable to air pollution?
por: Copur, Sidar, et al.
Publicado: (2022)

Chyluria Associated With Nephrotic-Range Proteinuria
por: Kaur, Amninder, et al.
Publicado: (2022)

Worsening proteinuria and renal function after intravitreal vascular endothelial growth factor blockade for diabetic proliferative retinopathy
por: Shye, Michael, et al.
Publicado: (2020)

Oncogenic mechanisms in renal insufficiency
por: Volovat, Simona Ruxandra, et al.
Publicado: (2020)

Idiopathic Chyluria with Nephrotic-range Proteinuria and Hypothyroidism
por: Uzu, Takashi, et al.
Publicado: (2018)

Sugar, salt, immunity and the cause of primary hypertension
por: Sánchez-Lozada, Laura G, et al.
Publicado: (2023)

Microfilaria associated macroscopic hematuria and nephrotic range proteinuria
por: Prakash, G. K., et al.
Publicado: (2016)

Post-acute COVID-19 syndrome and kidney diseases: what do we know?
por: Copur, Sidar, et al.
Publicado: (2022)

Citation classics: ranking of the top 100 most cited articles in nephrology
por: Montinaro, Vincenzo, et al.
Publicado: (2018)

Nephrotic-Range Proteinuria and Peripheral Edema in a Child: Not Only Idiopathic Nephrotic Syndrome
por: Dolcemascolo, Valentina, et al.
Publicado: (2016)

Primary Superior Lumbar Hernia with Nephrotic-range Orthostatic Proteinuria
por: Horino, Taro, et al.
Publicado: (2022)

Outcomes of minimal change disease without nephrotic range proteinuria
por: Son, Hyung Eun, et al.
Publicado: (2023)

Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reports
por: Torra, Roser, et al.
Publicado: (2021)

Tirzepatide and prevention of chronic kidney disease
por: Bosch, Catalina, et al.
Publicado: (2022)

Nonsecretory Multiple Myeloma and AL Amyloidosis Presenting with Nephrotic Range Proteinuria
por: Beyler Kilic, Ozlem, et al.
Publicado: (2015)

Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
por: Zhao, Jing-Li, et al.
Publicado: (2021)

An Unexpected Finding in a Patient with AKI, Nephrotic Range Proteinuria, and MGUS
por: Scurt, Florian G., et al.
Publicado: (2023)

Donor liquid biopsy and outcomes in kidney transplantation
por: Anfaiha-Sanchez, Miriam, et al.
Publicado: (2022)

The renal patient seen by non-renal physicians: the kidney embedded in the ‘milieu intérieur’
por: Perez-Villa, Felix, et al.
Publicado: (2020)

From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes
por: Quiroga, Borja, et al.
Publicado: (2022)

Coronavirus disease 2019 in chronic kidney disease
por: D’Marco, Luis, et al.
Publicado: (2020)

The unmet need of evidence-based therapy for patients with advanced chronic kidney disease and heart failure: Position paper from the Cardiorenal Working Groups of the Spanish Society of Nephrology and the Spanish Society of Cardiology
por: Ortiz, Alberto, et al.
Publicado: (2021)

Intravenous iron therapy and the cardiovascular system: risks and benefits
por: Del Vecchio, Lucia, et al.
Publicado: (2020)

Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease
por: Donate-Correa, Javier, et al.
Publicado: (2022)

PoCUS in nephrology: a new tool to improve our diagnostic skills
por: Romero-González, Gregorio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b9k4aac5b01fg0fijg8cn60btb